연구성과로 돌아가기
2023 연구자 정보 (140 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Heo, Nae-Yun (Heo, NY) |
Inje Univ, Haeundae Paik Hosp, Gimhae, South Korea Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Internal Med, Busan, South Korea |
LUY-9667-2024 Heo, Nae-Yun |
|
[JCR상위 4.5] HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY [JCR상위 8.7] Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial A Validation Study of 2021 AASLD Practice Guidance for SBP |
SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | lacid@korea.ac.kr;mothpickle@naver.com;eug203@naver.com;free93cool@gmail.com;drseo@korea.ac.kr;shkang0114@gmail.com;drkimmy@yonsei.ac.kr;baiksk@yonsei.ac.kr;khskhs@sch.ac.kr;liverkys@schmc.ac.kr;psyoung0419@gmail.com;bik.kim@samsung.com;DRPJY@yuhs.ac;jheo@pusan.ac.kr;sonjh@hanyang.ac.kr;H00175@paik.ac.kr;gihankhys@yuhs.ac;umsh@korea.ac.kr;gudwns21@korea.ac.kr; | ||
|
Hong, Gun Young (Hong, GY) |
Kwangju Christian Hosp, Kwangju, South Korea |
JCE-3602-2023 Kim, Eun Young |
|
[JCR상위 4.5] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Hong, Ji Hoon (Hong, JH) |
Seoul Natl Univ, Coll Med, Seoul, South Korea |
|
|
[JCR상위 4.5] PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH A HIGHER MORTALITY IN CIRRHOTIC PATIENTS: A MULTICENTER STUDY | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Huang, Daniel Q. Q. (Huang, DQ) |
제1저자 |
Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore |
LSJ-9214-2024 Huang, Daniel |
0000-0002-5165-5061 Huang, Daniel |
[JCR상위 4.5] Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | daniel_huang@nus.edu.sg;nobuharu.tamaki@gmail.com;psyoung0419@gmail.com;kurosaki@musashino.jrc.or.jp;h.marusawa@osaka-med.jrc.or.jp;matoshi@matsuyama.jrc.or.jp;Masachan44@gmail.com;laboratory@matsue.jrc.or.jp;kobashi0584@gmail.com;furuta-k@masuda.jrc.or.jp;izumi012@musashino.jrc.or.jp;beomkkim@yuhs.ac;sinndhn@hanmail.net; | |
|
Hur, Moon Haeng (Hur, MH) |
Seoul Natl Univ Hosp, Seoul, South Korea Seoul Natl Univ, Liver Res Inst, Dept Internal Med, Coll Med, Seoul 03080, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea |
|
0000-0001-5463-6782 Hur, Moon Haeng |
[JCR상위 4.5] PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH A HIGHER MORTALITY IN CIRRHOTIC PATIENTS: A MULTICENTER STUDY [JCR상위 24.1] Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study [JCR상위 8.7] Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study |
SCIE | 4.5 |
GASTROENTEROLOGY & HEPATOLOGY ONCOLOGY |
yoonjun@snu.ac.kr; mhhur@snu.ac.kr;alsrud627@snu.ac.kr;terryfungyip@gmail.com;e580306@ms31.hinet.net;vital@snu.ac.kr;dr.choi85@gmail.com;KSUKOREA@yuhs.ac;limys@amc.seoul.kr;psyoung0419@gmail.com;wonglaihung@mect.cuhk.edu.hk;sinndhn@gmail.com;jyj412@hanmail.net;sekim@hallym.or.kr;cypeng@mail.cmuh.org.tw;drshp@khu.ac.kr;5137ccy@gmail.com;hwiyoung@gmail.com;amelia86@naver.com;gandorie@gmail.com;noshin@hanyang.ac.kr;mseileen80@hanyang.ac.kr;sonjh@hanyang.ac.kr;dr486@eulji.ac.kr;jshim3927@gmail.com;jeongsw@schmc.ac.kr;choyk2004.cho@samsung.com;hskim@kdh.or.kr;mjjang2014@naver.com;yoonjun@snu.ac.kr;yoonjh@snu.ac.kr;pindra@empal.com; |
||
|
Hwang, Jaeseok (Hwang, J) |
Keimyung Univ, Daegu, South Korea |
|
|
[JCR상위 4.5] AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C☆ [JCR상위 4.5] HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY |
SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Hwang, Sangyoun (Hwang, S) |
Dongnam Inst Radiol & Med Sci, Busan, South Korea |
|
|
[JCR상위 4.5] REAL-WORLD EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB COMBINATION TREATMENT IN HIGH-RISK PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA [JCR상위 1.7] Real-world experience of atezolizumab plus bevacizumab combination treatment in high risk patients with advanced hepatocellular carcinoma |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | jheo@pusan.ac.kr; | ||
|
Idriz, Nevin (Idriz, N) |
Univ Med & Hosp Act Treatment Sofiamed, Sofia, Bulgaria |
|
|
[JCR상위 4.5] INITIAL EXPLORATION OF HEPATITIS B SURFACE ANTIGEN ( HBsAg) BLIPS FOLLOWING BEPIROVIRSEN TREATMENT: A POST HOC ANALYSIS OF THE B- CLEAR STUDY | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Izumi, Namiki (Izumi, N) |
Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan |
|
|
[JCR상위 4.5] Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | daniel_huang@nus.edu.sg;nobuharu.tamaki@gmail.com;psyoung0419@gmail.com;kurosaki@musashino.jrc.or.jp;h.marusawa@osaka-med.jrc.or.jp;matoshi@matsuyama.jrc.or.jp;Masachan44@gmail.com;laboratory@matsue.jrc.or.jp;kobashi0584@gmail.com;furuta-k@masuda.jrc.or.jp;izumi012@musashino.jrc.or.jp;beomkkim@yuhs.ac;sinndhn@hanmail.net; | ||
|
Jang, Byoung-Kuk (Jang, BK) |
Keimyung Univ, Sch Med, Daegu, South Korea |
|
|
[JCR상위 4.5] REAL-WORLD EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB COMBINATION TREATMENT IN HIGH-RISK PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA [JCR상위 4.5] HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY |
SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Jo, Hoon Gil (Jo, HG) |
Wonkwang Univ Coll Med & Hosp, Iksan, South Korea Wonkwang Univ, Coll Med & Hosp, Iksan, South Korea Wonkwang Univ, Dept Internal Med, Coll Med & Hosp, Iksan, South Korea |
|
|
[JCR상위 4.5] PROPOSAL OF A NOVEL SEROLOGICAL ALGORITHM COMBINING A FIBROSIS INDEX BASED ON FOUR AND SERUM MAC-2 BINDING PROTEIN GLYCOSYLATION ISOMER FOR ADVANCED FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE [JCR상위 1.7] The role of M2BPGi in screening for advanced hepatic fibrosis in diabetic patients [JCR상위 1.7] The role of M2BPGi for screening of advanced hepatic fibrosis in elderly patients [JCR상위 1.7] Fibrosis-4 and M2BPGi combination screening algorithm for screening advanced hepatic fibrosis in diabetes is cost-effective [JCR상위 1.7] Diagnostic efficacy of Mac-2 binding protein glycosylation isomer for predicting liver fibrosis in patients with metabolic associated fatty liver disease: multicenter cohort study |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY |
noshin@hanyang.ac.kr; gongori1004@gmail.com; |
||
|
Jun, Dae Won (Jun, DW) |
Hanyang Univ, Coll Med, Seoul, South Korea Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea Hanyang Univ, Hanyang Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea |
O-4529-2017 Jun, Dae Won |
0000-0002-2875-6139 Jun, Dae Won |
[JCR상위 4.5] PROPOSAL OF A NOVEL SEROLOGICAL ALGORITHM COMBINING A FIBROSIS INDEX BASED ON FOUR AND SERUM MAC-2 BINDING PROTEIN GLYCOSYLATION ISOMER FOR ADVANCED FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE [JCR상위 1.7] The role of M2BPGi in screening for advanced hepatic fibrosis in diabetic patients [JCR상위 1.7] The role of M2BPGi for screening of advanced hepatic fibrosis in elderly patients [JCR상위 1.7] Fibrosis-4 and M2BPGi combination screening algorithm for screening advanced hepatic fibrosis in diabetes is cost-effective [JCR상위 1.7] Diagnostic efficacy of Mac-2 binding protein glycosylation isomer for predicting liver fibrosis in patients with metabolic associated fatty liver disease: multicenter cohort study [JCR상위 24.1] Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study [JCR상위 8.7] Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study |
SCIE | 1.7 |
GASTROENTEROLOGY & HEPATOLOGY ONCOLOGY |
noshin@hanyang.ac.kr; gongori1004@gmail.com; yoonjun@snu.ac.kr; mhhur@snu.ac.kr;alsrud627@snu.ac.kr;terryfungyip@gmail.com;e580306@ms31.hinet.net;vital@snu.ac.kr;dr.choi85@gmail.com;KSUKOREA@yuhs.ac;limys@amc.seoul.kr;psyoung0419@gmail.com;wonglaihung@mect.cuhk.edu.hk;sinndhn@gmail.com;jyj412@hanmail.net;sekim@hallym.or.kr;cypeng@mail.cmuh.org.tw;drshp@khu.ac.kr;5137ccy@gmail.com;hwiyoung@gmail.com;amelia86@naver.com;gandorie@gmail.com;noshin@hanyang.ac.kr;mseileen80@hanyang.ac.kr;sonjh@hanyang.ac.kr;dr486@eulji.ac.kr;jshim3927@gmail.com;jeongsw@schmc.ac.kr;choyk2004.cho@samsung.com;hskim@kdh.or.kr;mjjang2014@naver.com;yoonjun@snu.ac.kr;yoonjh@snu.ac.kr;pindra@empal.com; |
||
|
Kang, Yeowool (Kang, Y) |
제1저자 | Dong A Univ, Busan, South Korea |
|
|
[JCR상위 4.5] PROPOSAL OF A NOVEL SEROLOGICAL ALGORITHM COMBINING A FIBROSIS INDEX BASED ON FOUR AND SERUM MAC-2 BINDING PROTEIN GLYCOSYLATION ISOMER FOR ADVANCED FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | ||
|
Khaertynova, Ilsiyar (Khaertynova, I) |
Kazan State Med Univ, Kazan, Russia |
|
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Kim, Bumseok (Kim, B) |
Jeonbuk Natl Univ, Biosafety Res Inst, Iksan 54596, South Korea Jeonbuk Natl Univ, Coll Vet Med, Iksan 54596, South Korea |
ADR-9663-2022 Kim, Soo-Yeon |
|
[JCR상위 4.5] ALPHA-1 ANTITRYPSIN/ PROTEINASE 3 IMBALANCE EXERTS PROTEOLYTIC REGULATION ON INTERLEUKIN-32 GAMMA TO PROMOTE NONALCOHOLIC STEATOHEPATITIS | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY |
페이지 이동: